Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Breastfeeding during early life reduces need for pacifiers

05 Nov 2019

Exclusive breastfeeding (EB) for the first 6 months after birth appears to reduce pacifier-sucking behaviours at 12 months of life, a recent study has found.

Researchers enrolled 1,307 infants who were followed up to 12 months of life. Breastfeeding patterns were assessed 4 and 6 months after birth. Infants were categorized into four breastfeeding types: exclusive, predominant, complementary or none. The effect of breastfeeding type on pacifier behaviours was the primary outcome.

Of the participants, majority did not use pacifiers at 12 months (n=590; 51.5 percent male); the remaining 447 did (54.1 percent male). Using month 4 observations, researchers found that infants who had been complementarily breastfed or who had not been breastfed at all were more likely to exhibit pacifier-sucking behaviours at 12 months.

The same was true for children whose breastfeeding patterns were observed at 6 months. In comparison, exclusive and predominant breastfeeding seemed to attenuate the need for pacifiers.

Logistic regression analysis found that no (adjusted relative risk [RR], 2.67, 95 percent confidence interval [CI], 2.24–3.17) and complementary (adjusted RR, 1.68, 95 percent CI, 1.39–2.02) breastfeeding for the first 4 months of life were significant risk factors for pacifier behaviours at 12 months. Risk estimates were calculated in comparison to EB.

Similarly, no (adjusted RR, 3.30, 95 percent CI, 2.40–4.54) and complementary (adjusted RR, 1.43, 95 percent CI, 1.03–2.00) breastfeeding during the first 6 months of life correlated significantly with a higher likelihood of pacifier use after 12 months.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.